Breast cancer is considered a major health problem in western countries, and indeed it constitutes the most common cancer among women in the European Union [48]. A study developed in by the American Cancer Society estimates that in the United States between one in eight and one in twelve women will develop breast cancer during their lifetime [1]. This proportion is reduced in our country, Catalonia, where it is estimated that one in sixteen women will develop breast cancer during their lifetime [58].
In the European Community, breast cancer represents of cancer deaths and the of all cancer cases [47]. Nearly of all breast cancer deaths occur in women diagnosed between ages and years. In the United States, for instance, breast cancer remains the leading cause of death for women in their forties [21].
However, although breast cancer incidence has increased over the past decade, breast cancer mortality has declined among women of all ages [162]. This favourable trend in mortality reduction is considered to be related to the widespread adoption of mammography screening [3,39,71,162,170,176] which allows to detect the cancer at its early stages, and to the improvements made in breast cancer treatment [21].